Correlation Between Aion Therapeutic and Canntab Therapeutics
Can any of the company-specific risk be diversified away by investing in both Aion Therapeutic and Canntab Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aion Therapeutic and Canntab Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aion Therapeutic and Canntab Therapeutics Limited, you can compare the effects of market volatilities on Aion Therapeutic and Canntab Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aion Therapeutic with a short position of Canntab Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aion Therapeutic and Canntab Therapeutics.
Diversification Opportunities for Aion Therapeutic and Canntab Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Aion and Canntab is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Aion Therapeutic and Canntab Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canntab Therapeutics and Aion Therapeutic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aion Therapeutic are associated (or correlated) with Canntab Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canntab Therapeutics has no effect on the direction of Aion Therapeutic i.e., Aion Therapeutic and Canntab Therapeutics go up and down completely randomly.
Pair Corralation between Aion Therapeutic and Canntab Therapeutics
If you would invest 0.68 in Aion Therapeutic on September 14, 2024 and sell it today you would lose (0.27) from holding Aion Therapeutic or give up 39.71% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 98.44% |
Values | Daily Returns |
Aion Therapeutic vs. Canntab Therapeutics Limited
Performance |
Timeline |
Aion Therapeutic |
Canntab Therapeutics |
Aion Therapeutic and Canntab Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aion Therapeutic and Canntab Therapeutics
The main advantage of trading using opposite Aion Therapeutic and Canntab Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aion Therapeutic position performs unexpectedly, Canntab Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canntab Therapeutics will offset losses from the drop in Canntab Therapeutics' long position.Aion Therapeutic vs. Amexdrug | Aion Therapeutic vs. Antisense Therapeutics Limited | Aion Therapeutic vs. Alterola Biotech | Aion Therapeutic vs. Cannara Biotech |
Canntab Therapeutics vs. Bionoid Pharma | Canntab Therapeutics vs. CTT Pharmaceutical Holdings | Canntab Therapeutics vs. Alterola Biotech | Canntab Therapeutics vs. Crescita Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |